FDA Warning Epinephrine can lead to Stress Cardiomyopathy

Epinephrine was approved on May 23, 1984, to treat cardiac arrest and anaphylaxis. Endo International and GeoPharma, Inc manufacture the drug. Epinephrine, also known as adrenaline, is a hormone that is secreted by the adrenal glands. Adrenalin (without the e) was originally used as a […]

Nov 21, 2017

FDA Warns Epinephrine Use Can Lead to Stress Cardiomyopathy
FDA Warning Carafate linked to Pulmonary & Cerebral Emboli

The FDA approved Carafate (sucralfate) in 1981 for the short-term treatment of active duodenal ulcers. A duodenal ulcer is a sore on the upper part of the small intestine and is very common with more than 200,000 cases in the U.S. every year. Carafate, an […]

Nov 21, 2017

FDA Warns Carafate (sucralfate) May Cause Pulmonary & Cerebral Emboli
FDA Warning Statin Drugs Linked to Interstitial Lung Disease

Statin drugs lower the level of cholesterol in the blood by decreasing the production of cholesterol by the liver. Statins work by blocking hydroxy-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), the enzyme in the liver that is responsible for producing cholesterol. Although cholesterol is essential to the […]

Nov 21, 2017

FDA Warns Cholesterol Lowering Statin Drugs Can Cause Interstitial Lung Disease
FDA Warning Tanzeum linked to Anaphylaxis Reaction

Tanzeum Tanzeum (albiglutide) is an injectable diabetes medication that was approved by the U.S. Food and Drug Administration (FDA) in 2014. A glucagon-like peptide (GLP-1) receptor agonist, Tanzeum is used, along with diet and exercise, to help control blood sugar levels in those with type […]

Nov 21, 2017

Tanzeum (albiglutide) Discontinued After FDA Warns Of Risk Of Anaphylaxis Reaction